Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Get Free Report) Chairman Stefano Pessina acquired 832,258 shares of Walgreens Boots Alliance stock in a transaction dated Sunday, April 27th. The shares were acquired at an average price of $11.01 per share, with a total value of $9,163,160.58. Following the completion of the purchase, the chairman now owns 145,621,079 shares in the company, valued at approximately $1,603,288,079.79. The trade was a 0.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink.
Walgreens Boots Alliance Stock Down 0.4 %
Walgreens Boots Alliance stock opened at $10.93 on Wednesday. The company's 50-day moving average price is $10.96 and its two-hundred day moving average price is $10.24. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock has a market cap of $9.45 billion, a P/E ratio of -1.07, a P/E/G ratio of 1.31 and a beta of 0.67. Walgreens Boots Alliance, Inc. has a twelve month low of $8.08 and a twelve month high of $18.83.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last announced its earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The company had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The firm's quarterly revenue was up 4.1% compared to the same quarter last year. During the same quarter last year, the company earned $1.20 earnings per share. As a group, analysts expect that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.
Analysts Set New Price Targets
WBA has been the topic of several analyst reports. Royal Bank of Canada upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a "sector perform" rating in a report on Wednesday, January 15th. Bank of America increased their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a report on Monday, January 13th. Truist Financial lowered their target price on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research report on Sunday. They issued a "hold" rating for the company. Finally, Evercore ISI upped their target price on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an "in-line" rating in a report on Monday, January 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $10.59.
Get Our Latest Analysis on Walgreens Boots Alliance
Institutional Investors Weigh In On Walgreens Boots Alliance
A number of institutional investors have recently modified their holdings of WBA. U.S. Capital Wealth Advisors LLC bought a new position in Walgreens Boots Alliance during the first quarter worth about $147,000. Concurrent Investment Advisors LLC grew its position in shares of Walgreens Boots Alliance by 28.2% during the 1st quarter. Concurrent Investment Advisors LLC now owns 13,924 shares of the pharmacy operator's stock worth $156,000 after purchasing an additional 3,064 shares in the last quarter. Bank of New York Mellon Corp increased its holdings in shares of Walgreens Boots Alliance by 3.9% during the first quarter. Bank of New York Mellon Corp now owns 5,645,380 shares of the pharmacy operator's stock worth $63,059,000 after purchasing an additional 212,997 shares during the period. Elite Financial Inc. acquired a new stake in shares of Walgreens Boots Alliance in the first quarter valued at approximately $59,000. Finally, IFM Investors Pty Ltd boosted its stake in shares of Walgreens Boots Alliance by 19.7% in the first quarter. IFM Investors Pty Ltd now owns 151,527 shares of the pharmacy operator's stock valued at $1,693,000 after buying an additional 24,890 shares during the period. Institutional investors own 58.59% of the company's stock.
Walgreens Boots Alliance Company Profile
(
Get Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
